Table 8.
Graft Type | Material | Fabrication | Reference |
---|---|---|---|
Synthetic | Dacron, ePTFE, PU, PCL, PLCL, PGA, PLA, PLLA, PLGA, PGS, PEUU | Electrospinning, molding, 3D Printing, laser degradation, hydrogel | [45,47,53,58,60,62,68,72,74,80,82] |
Natural | Collagen, elastin, fibrin, hyaluronic acid, silk fibroin, gelatin, chitosan | Electrospinning, molding, rolling, 3D Printing, laser degradation, hydrogel | [44,54,59] |
Cell-secreted ECM | Hydrogel, rolling, self-assembled cell sheets | [66,79] | |
Native ECM | Decellularization or crosslinking of native tubular organs (vessels, ureters and small intestinal submucosa) | [46,49,50,55,58,61,65,67,69,70,75,76,78,81] | |
Hybrid | Combination of above | Combination of above, e.g., in-body tissue architecture (IBTA)/ in vivo tissue engineering | [51,52,56,57,63,64,71,73,77,83] |
Dacron: Polyethylene terephthalate (PET); ePTFE: expanded polytetrafluoroethylene; PU: Polyurethane; PCL: polycaprolactone; PLCL: poly(L-lactide-co-ε-caprolactone); PGA: polyglycolic acid; PLA: poly-lactic acid; PLLA: poly-l-lactic acid; PLGA: poly (lactide-co-glycolide); PGS: Poly(glycerol-sebacate); PEUU: poly(ether urethane urea); and ECM: extracellular cellular matrix.